Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Proteomic Analysis of Patients Undergoing Bariatric Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Status
- RECRUITING
- Phase
- N/A
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Multi-center Screening for Serum M Protein
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
SIL as Maintenance Therapy in Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Elranatamab in Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
- Status
- RECRUITING
- Phase
- N/A
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Risk Stratification and MRD-driven Maintenance for MM After ASCT
- Status
- RECRUITING
- Phase
- NA
A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
- Status
- RECRUITING
- Phase
- N/A
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Status
- RECRUITING
- Phase
- PHASE3